Sinovant Sciences and Nabriva Therapeutics Announce Positive

Sinovant Sciences and Nabriva Therapeutics Announce Positive Topline Results from Phase 3 Trial of Lefamulin in Chinese Adults with Community Acquired Bacterial Pneumonia (CABP)

Sinovant Sciences and Nabriva Therapeutics Announce Positive Topline Results from Phase 3 Trial of Lefamulin in Chinese Adults with Community Acquired Bacterial Pneumonia (CABP)
yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

, Yahoo , Sumitomo Pharmaceuticals , Nabriva Therapeutics , Sumitomo Dainippon Pharma , China , Huzhou , Moxifloxacin , Herapeutics , Iopharmaceutical Company , Chinese Patients , Pharmaceuticals , Efamulin , Clinical Trials , யாகூ , ஸூமிடோமொ மருந்துகள் , ஹினா ,